October 14, 2026 • 7:00am EDT Axogen, Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026
October 1, 2026 • 5:19pm EDT Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair
